Ortoli Rosenstadt and Olshan Frome Wolosky advised Springview Holdings Ltd on the offering. Springview Holdings Ltd announced the pricing of its initial public offering of 1,500,000...
Springview’s $6.0 Million Initial Public Offering
Mangoceuticals’ $5 Million Initial Public Offering
The Loev Law Firm, PC advised Mangoceuticals and Olshan Frome Wolosky LLP Boustead Securities, LLC, as sole managing underwriter on the IPO. Mangoceuticals, Inc. (“MangoRx” or...
Jeffrey R. Westphal’s $23 Million Block Trade Offering of Vertex
Olshan Frome Wolosky LLP represented Jeffrey R. Westphal, Latham & Watkins LLP represented Vertex and Skadden, Arps, Slate, Meagher & Flom LLP represented Goldman Sachs. Jeffrey...
Blink Charging’s $200 Million Acquisition of SemaConnect
Olshan Frome Wolosky acted as counsel to Blink Charging Co., while DLA Piper advised SemaConnect on the deal. SemaConnect, Inc., a leading provider of electric vehicle...
Blink Charging’s $200 Million Acquisition of SemaConnect
Olshan Frome Wolosky acted as counsel to Blink Charging Co., while DLA Piper advised SemaConnect on the deal. SemaConnect, Inc., a leading provider of electric vehicle...
Star Equity Holdings’ $14.25 Million Common Stock Offering
Olshan Frome Wolosky represented Star Equity Holdings in the offering. Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) closed its underwritten public offering of 9,500,000 shares of its common...
Alzamend Neuro’s $14.4 Million Initial Public Offering
Olshan Frome Wolosky LLP advised Alzamend Neuro and Ault Global Holding, while Haynes & Boone LLP represented the underwriter in the offering. Alzamend Neuro, Inc. executed...
Anebulo Pharmaceuticals’ $21 Million Initial Public Offering
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
Anebulo Pharmaceuticals’ $21 Million Initial Public Offering
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
IMAC’s $19.55 Million Shares Offering
Olshan Frome Wolosky LLP advised IMAC Holdings on the offering. IMAC Holdings, Inc. (Nasdaq: IMAC) executed a $19.55 million underwritten follow-on public offering of its shares...